Single-Center Experience with Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic Osteosarcoma

Author(s):
Verschoor, A.J. (0000-0001-9972-4241); Speetjens, F.M.; Dijkstra, P.D.S.; Fiocco, M.; Sande, M.A.J. van de; Bovee, J.V.M.G. (0000-0003-1155-0481); Gelderblom, H.
Published
2019
Publication type
Article / Letter to editor
OsteosarcomaChemotherapyIfosfamideSurvivalMetastasis
Date issued
2019-12-19
Language
English
Is part of
Oncologist
hdl
1887/120872
doi
10.1634/theoncologist.2019-0528